The mean age of participants ranged from 16 to 70 years, injury duration ranged from 2 days to 15 years. Thirteen included trials enrolled acute/subacute patients and 8 trials enrolled chronic ...
After systematic assessment, no studies that met inclusion included participants with specifically acute LBP. Therefore, extracted data reflects only populations with subacute and chronic LBP. Data on ...
Nerinetide is under clinical development by NoNO and currently in Phase III for Acute Ischemic Stroke. According to GlobalData, Phase III drugs for Acute Ischemic Stroke have a 13% phase transition ...